Michael E. Nursey - 18 Feb 2026 Form 4 Insider Report for Amerant Bancorp Inc. (AMTB)

Reporting relationship: Officer
Issuer ticker: AMTB
Reported as of: 18 Feb 2026
Net transaction value: -$4,185
SEC form: 4
Accepted by SEC: 20 Feb 2026, 18:35:46 UTC
Prior SEC filing: 19 Feb 2026
Next SEC filing: 04 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Julio Pena, as Attorney-in-Fact for Michael E. Nursey

Key filing fact

Michael E. Nursey filed Form 4 for Amerant Bancorp Inc. (AMTB) on 20 Feb 2026.

Key facts

This page summarizes Michael E. Nursey's Form 4 filing for Amerant Bancorp Inc. (AMTB).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 20 Feb 2026, 18:35.

Change

Previous filing in this sequence was filed on 19 Feb 2026.
Current net transaction value: -$4,185.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002098589 Primary reporting owner

Nursey Michael E.

Relationship: Officer
Address: C/O AMERANT BANCORP INC., 220 ALHAMBRA CR., 12TH FLOOR, CORAL GABLES
Signature: /s/ Julio Pena, as Attorney-in-Fact for Michael E. Nursey
Signature date: 20 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMTB transaction

Class A Common Stock

Options Exercise

Transaction value: $0
Shares: +666
Change %: +66%
Price: $0.000000
Shares after: 1,681
Date: 18 Feb 2026
Ownership: Direct
Footnotes: F1

AMTB transaction

Class A Common Stock

Tax liability

Transaction value: $4,185
Shares: -187
Change %: -11%
Price: $22.38
Shares after: 1,494
Date: 18 Feb 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AMTB transaction Derivative

Restricted Stock Units LTI 2025

Options Exercise

Transaction value: $0
Shares: -666
Change %: -33%
Price: $0.000000
Shares after: 1,334
Date: 18 Feb 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 666
Exercise price: $0.000000
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each RSU is the economic equivalent of one share of Class A Common Stock.

Footnote F2

Reflects the shares of Class A Common Stock that were surrendered in order to satisfy the reporting person's tax withholding obligation upon the vesting of RSUs.

Footnote F3

On February 18, 2025, Mr. Nursey was awarded 2,000 RSUs each representing the right to receive, following vesting, one share of Class A Common Stock. The award vests in substantially equal installments on each of the first three anniversaries of the date of grant, provided that Mr. Nursey remains in the continuous service of the Company or a subsidiary through each such date.